Serum total cholesterol, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol, apolipoprotein A-I and apolipoprotein B were evaluated as potential indicators of the risk of coronary artery disease in young ( < 46 years) normocholesterolaemic, non-diabetic men who had previously sustained a myocardial infarction (n = 50) and in healthy age and sex matched controls (n = 122) with a similar socioeconomic background.
Introduction
Risk factors for the development of myocardial infarction, particularly lipid abnormalities, have been considered to be more pronounced in young patients than in middle aged or elderly individuals."2 However, the risk ofcoronary artery disease is only partially characterized by lipid abnormalities since there are many individuals who develop the disease but have normal serum lipid and lipoprotein cholesterol levels.3 Though the disease may be related to the presence of other risk factors such as hypertension, diabetes mellitus and cigarette smoking in some of these individuals, the presence of coronary artery disease in a significant number of patients remains unexplained. Moreover, age-dependent degenerative disease in young patients with coronary artery disease may be considered minimal. Hence interest has focused on measurements of apolipoproteins because of their pivotal roles in cholesterol transport and metabolism. 4 Associations between apolipoprotein B (apo B) and apolipoprotein A-I (apo A-I) concentrations and coronary artery disease have been confirmed in several case control studies.58 Opinions are divided, however, as to whether increases in apo B, or decreases in apo A-I, are better indicators of coronary artery disease risk than total cholesterol, low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol.9-" Recent studies which have addressed this question have produced confficting results,9'2 though the majority of studies have suggested that concentrations of apolipoproteins, in particular apo B and possibly also apo A-I, discriminate better than cholesterol and lipoprotein concentrations between patients with coronary artery disease and controls.
Accordingly the present investigation focuses on serum apo A-I and apo B in young Indian survivors of myocardial infarction and healthy age and sex matched controls. The object of the study was to investigate the importance of apolipoproteins as risk factors in a sample ofyoung normocholestero-laemic and non-diabetic Indian males with myocardial infarction.
Patients and methods
Male patients below the age of 46 years attending the Ischaemic Heart Disease Clinic at the R.K. Khan Hospital and who fulfilled the following prerequisites were considered for this study: (1) admission to the coronary care unit at R.K. Khan Hospital with documented myocardial infarction at least 6 months previously. The diagnosis of myocardial infarction was based on a typical history of central chest pain, accompanied by unequivocal electrocardiographic changes of acute myocardial infarction and transient rise in creatine kinase levels. (2) Normal glucose tolerance test and total serum cholesterol < 6.5 mmol/l. The cut-off point for total cholesterol was chosen in order to exclude patients with high values, thus permitting an investigation of normocholesterolaemic, nondiabetic patients. These tests were performed routinely 3 months after the acute episode of myocardial infarction. (3) Stable clinical condition. Patients on diuretics were excluded whilst treatment with beta blockers and calcium channel blockers was not a criterion for exclusion.
Consecutive patients attending the clinic and who fulfilled these criteria were recalled for repeat cholesterol, triglyceride, lipoprotein and apolipoprotein analyses. Any patient in whom the repeat metabolic evaluation revealed total cholesterol > 6.5 mmol/l was excluded. The first 50 consecutive patients who satisfied all the criteria were selected. The study group hence consisted of 50 non-diabetic patients between the ages of26 and 45 years with total cholesterol < 6.5 mmol/l on two separate occasions. Of these patients, 2 B) .'5 The intra-and inter-assay coefficients ofvariation for both apo A-I and apo B determinations were 5%.
The importance of apolipoprotein in survivors was further evaluated by a comparison with a subset of controls that were matched for cholesterol with the myocardial infarct survivors.
Statistical analyses
Proportions were compared using the chi-square test with Yates' correction. Statistical significance for differences in continuous variables between groups was tested using one way analysis of variance and two-tailed t-test. Triglyceride values were log transformed before statistical analysis but untransformed values are given in the text and tables. Stepwise multiple discriminant analyses were performed to determine the sets of independent lipoprotein and apolipoprotein variables giving the best discrimination between survivors and controls. The statistical analyses were performed with BMDP statistical software (University of California Press, Berkeley, California). All data in text and tables are means and 1 standard deviation (s.d.).
Ethical consideration
Prior to the study informed consent was obtained from all subjects. The study protocol had been approved by the hospital administration.
Results
Clinical data for the patient and control groups are listed in Table I . At the time of the metabolic evaluation the smoking histories of the patients were similar to the controls. However there was a significant larger number of ex-smokers in the patient group, the majority of whom had stopped smoking at the time of the myocardial infarction. Although a history of myocardial infarction in first degree relatives was encountered more frequently in the patients, the difference was not statistically significant.
Men with myocardial infarction had significantly higher levels of serum total cholesterol (P < 0.001), triglycerides (P <0.005), LDL-cholesterol (P < 0.005) and apo B (P < 0.0001) and significantly lower levels of HDL-cholesterol (P<0.01) than healthy age matched controls (Table II) . Apolipoprotein A-I levels did not differ between patients and controls. Significantly higher total cholesterol/HDL-cholesterol and lower apo A-I/ apo B ratios were noted in patients when compared to controls (Table II) . Stepwise discriminant analyses were performed to determine which variables were most important in differentiating between men with myocardial infarction and those without. Variables included in the analysis included body mass index, family history of myocardial infarction, total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, apo A-I, apo B and the ratios of total cholesterol to HDL-cholesterol and apo A-I to apo B. The first (Table IV) . Serum apo B > 1.14 (90th percentile) was found in 32% of patients with myocardial infarction (Table V) . From Table V it can also be seen that the separation between patients and controls was greatest for apo B, there being a 3.2-fold difference for apo B compared to a 1.6-fold difference for apo A-I in the observed/expected ratios of the two groups.
There was no significant difference in the mean serum lipid, lipoprotein and apolipoprotein values in patients on beta blockers (n = 19) when compared to patients not on these drugs (data not presented).
Discussion
In this study of young, normocholesterolaemic, non-diabetic Indian men, we found that apo B levels were better markers for myocardial infarction than lipid and lipoprotein measurements. The main finding in this study is, in general, consistent with previous work by other investigators.5'7 9' 1,12 In this study, although subjects with total cholesterol below 6.6 mmol/l were selected, the mean cholesterol of the patients was significantly higher than the controls. In addition significant differences were demonstrated in the mean values of LDL-cholesterol, HDL-cholesterol, triglycerides, apo B and in the ratios of total cholesterol/HDLcholesterol and apo A-I/apo B by univariate analysis, whilst apo A-I levels between the groups were similar. However, stepwise multiple discriminant analysis indicated that apo B had the best discriminative power between survivors and controls. The percentage success for exact classification using apo B was 74% for patients and 66% for controls.
Neither the inclusion of other lipoprotein or lipid concentrations nor the ratios of total cholesterol/ HDL-cholesterol or apo A-I/apo B improved the discrimination provided by apo B. There is much debate on whether serum triglyceride is a risk factor for coronary artery disease and this issue remains unresolved.'8 In our study, whilst there was a significant difference in serum triglyceride concentrations between patients and controls by univariate analysis, multivariate analysis failed to select this variable as a significant factor.
The findings in this study should be interpreted with due regard to its cross-sectional design and selection of patients. Significant changes in the associations between lipids and myocardial infarction may occur during the time between the onset of the disease and the metabolic evaluation as a result of diet modification and change of life style. However, such alterations are less probable in these patients since their total cholesterol levels were normal; they were generally well following their infarction, had all returned to work and were in a stable clinical condition at the time of the study. Sufficient time was allowed between myocardial infarction and the study to reverse the temporary effects of acute phasic reactions on cholesterol, triglycerides, lipoproteins and apolipoproteins. 19, 20 Since no difference in the lipid profile was observed between patients with or without beta blockers, and patients on diuretics were excluded, medication cannot account for the differences observed between the patients and controls. Apolipoprotein abnormalities have been demonstrated in relatives of patients with coronary artery disease.' It is unlikely that familial history of myocardial infarction influenced our findings. Despite a high frequency of positive family history in both patients and controls, the difference was not statistically significant and, furthermore, discriminant analysis performed separately in subjects with and without a positive history yielded identical results.
Our study by virtue of its cross-sectional design does not allow conclusions to be drawn about the predictive value of the various lipid, lipoprotein and apolipoprotein levels. Such a consideration will have to await results from prospective studies. Nevertheless the results of the present study indicate that apo B levels are superior to lipoprotein determinations as a marker for coronary artery disease in young non-diabetic, normocholesterolaemic patients with myocardial infarction.
